Healthcare Solution Provider,
BroadHill Ventures!

About Us

While we partner with companies at all stages, we prefer to be involved from the very beginning, to help setting the strategy, recruiting key R&D scientists and providing connections to corporates.
We are fortunate to have been the first investor in major biotechs in Korea, such as PH Pharma, ViroMed, Qurient.
We aim to help aspiring entrepreneurs to build great companies, from bench to IPO and beyond.


Seok Won Yoon
Univ. of Calgary Microbiology MS
SNU, Food S&T, BS
SBI Investment
Hanhwa Investment
Daewoong Pharma
Sung Soon Cho
Sogang Univ. Biology/Business BS
Maple Investment
UTC Investment
I-Best Investment
Joon Hyuk Park
Yonsei Univ.Mechanical Eng. MS
SBI Investment
LG Elecronics
Cisco Systems
Don Kim
King’s College Neuroscience Ph.D
SBI Investment
Dong-A Pharm
Heon Ju Lee
MIT Mechanical Eng. Ph.D
Texas A&M Mechinical Eng. MS
Korea Univ. Mechanical Eng. BS
Rokit Healthcare
Hanyang Univ.
Kyung Ho Jeong
Korea National Open Univ.
Commerce & Trade, BS
Samho Green Investment
GNTech Investment
Hanhwa Investment

Cross-border healthcare platform company with diversified clinical stage NCE/NBE pipelines


Biotechnology company with focus on the development of DNA, Protein and cell-based biotherapeutics


Biotechnology company with unique virtual R&D model, developing novel therapeutics against infectious disease and inflammation


Pharmaceutical company focusing on the development of IMDs


Protein based drug discovery and development company


Clinical-stage biotech company, developing human therapeutic antibodies for the treatment of cancer and inflammatory diseases


Biotech with focus on developing stem cell therapies for CNS disorders


Medical devices company with focus on the manufacture of skin care and personal beauty equipment


The largest Pre-clinical CRO in Korea


Pre-clinical CRO specializing in project management of IND-enabling studies


11F, Teheran-ro 528, Gangnam-gu, Seoul, Republic of Korea